How many stocks does BROWN BROTHERS HARRIMAN & CO own?

As of Q4 2019, BROWN BROTHERS HARRIMAN & CO holds 1,108 positions in their 13F portfolio.

What is BROWN BROTHERS HARRIMAN & CO's largest holding?

GOOG at 5.9% of portfolio, worth $923.6M.

What is BROWN BROTHERS HARRIMAN & CO's total portfolio value?

$15.6B as of Q4 2019, tracked across 1,108 holdings.

Is BROWN BROTHERS HARRIMAN & CO a hedge fund?

BROWN BROTHERS HARRIMAN & CO is an institutional investment manager required to file SEC 13F reports. This includes hedge funds, mutual funds, pension funds, and other institutions managing over $100M.

How often does BROWN BROTHERS HARRIMAN & CO report?

13F filings are due quarterly, approximately 45 days after each quarter end.

How has BROWN BROTHERS HARRIMAN & CO's portfolio changed in Q4 2019?

View BROWN BROTHERS HARRIMAN & CO's latest portfolio changes, new positions, and exits for Q4 2019 on HoldingsIntel.

What is BROWN BROTHERS HARRIMAN & CO's investment strategy?

BROWN BROTHERS HARRIMAN & CO is classified as a Steady Compounder fund based on HoldingsIntel's Fund DNA analysis of 6 behavioral dimensions.

BROWN BROTHERS HARRIMAN & CO

Institutional investor · Portfolio as of Q4 2019

SEC EDGAR SourceSEC Filings

$15.6B

AUM

1,108

Positions

Q4 2019

Filing

Rating · 2.5

Quarterly Portfolio Change

Activity profile

$ moved · Q4'19

New1%Increased50%Decreased48%Exited1%

Composition

Equity vs derivatives

Equity100%Puts0%Calls0%

Holding period

Avg 2.6 quarters

<1Q8%1-4Q90%1-2Y0%2Y+2%

Q4 2019 Summary

Active quarter - 104 new positions, 261 exits, 255 increased. Top move: AOS (INCREASED, conviction 72). Portfolio: $15.6B across 1108 positions.

Portfolio Allocation

Top holdings by portfolio weight

GOOG5.90%

ORCL5.39%

BRK/B5.24%

CMCSA5.16%

USB4.22%

FLT3.87%

CPRT3.78%

ZTS3.31%

LIN3.17%

DEO2.70%

Other2.69%

Sector Breakdown

Portfolio allocation by GICS sector

Financial Services18.50%

Industrials14.14%

Consumer Defensive12.94%

Communication Services12.60%

Healthcare12.46%

Unknown8.64%

Technology8.58%

Basic Materials6.95%

Consumer Cyclical4.21%

Real Estate0.55%

Other0.44%

Fund DNA

Behavioral investing profile

Steady Compounder90%- primarily Financial Services, Industrials, Consumer Defensive

Compare DNA across all funds

Fund Rating

7-dimension quality assessment

Solid(2.5 / 5.0)

Track Record56

Conviction38

Concentration0

Upgrade to see all dimensions

Position Outcomes

Best and worst performing positions by estimated return

Top Winners

COHR3Q held

COHERENT INC

Avg $36.56 · $864 est. P&L

Est. P&L

+787.58%

TDIV4Q held

FIRST TR EXCHANGE TRADED FD

Avg $33.38 · $267,894 est. P&L

Est. P&L

+243.20%

AUPH4Q held

AURINIA PHARMACEUTICALS INC

Avg $6.50 · $89,310 est. P&L

Est. P&L

+211.38%

Top Losers

Upgrade to Pro to see the worst-performing positions.

View plans

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Holdings1,108 positions

Export CSV(Pro)

Activity:

Stock	Shares	Value	Weight	Price Trend	Avg Buy	Est. P&L	Held	Conviction
GOOG ALPHABET INC	690,785	$923.6M	5.9%	—	$58.01	+14.31%	4 qtrssince 2019-Q1	Decreased 0
ORCL ORACLE CORP	15.9M	$843.5M	5.4%	—	$48.47	-0.60%	4 qtrssince 2019-Q1	Decreased 0
BRK/B BERKSHIRE HATHAWAY INC DEL	3.6M	$819.4M	5.2%	—	$201.45	+12.07%	4 qtrssince 2019-Q1	Increased 63
CMCSA COMCAST CORP NEW	18M	$807.6M	5.2%	—	$31.19	+14.15%	4 qtrssince 2019-Q1	Increased 64
USB US BANCORP	11.1M	$660.8M	4.2%	—	$36.41	+25.49%	4 qtrssince 2019-Q1	Decreased 0
FLTDelisted FLEETCOR TECHNOLOGIES INC	2.1M	$605.2M	3.9%	—	—	—	4 qtrssince 2019-Q1	Decreased 0
CPRT COPART INC	6.5M	$591.5M	3.8%	—	$15.15	+49.97%	4 qtrssince 2019-Q1	Decreased 0
ZTS ZOETIS INC	3.9M	$517.5M	3.3%	—	$94.87	+31.92%	4 qtrssince 2019-Q1	Decreased 0
LINDE PUBLIC LIMITED COMPANY(LIN)	2.3M	$496.8M	3.2%	—	$160.15	+21.18%	4 qtrssince 2019-Q1	Decreased 0
DEO ADR DIAGEO PLC	2.5M	$422.8M	2.7%	—	$137.29	+4.28%	4 qtrssince 2019-Q1	Decreased 0
ALLE ALLEGION PLC	3.4M	$420.2M	2.7%	—	$89.19	+28.82%	4 qtrssince 2019-Q1	Decreased 0
NVS ADR NOVARTIS AG	4.4M	$415.4M	2.7%	—	$68.30	+9.75%	4 qtrssince 2019-Q1	Decreased 0
AJG GALLAGHER ARTHUR J & CO	4.3M	$411.8M	2.6%	—	$83.02	+6.58%	4 qtrssince 2019-Q1	Increased 60
BF/B BROWN FORMAN CORP	5.7M	$382M	2.4%	—	$47.98	+25.49%	4 qtrssince 2019-Q1	Decreased 0
CE CELANESE CORP DEL	3M	$372.2M	2.4%	—	$88.19	+24.28%	4 qtrssince 2019-Q1	Decreased 0
HSIC SCHEIN HENRY INC	5.5M	$365.8M	2.3%	—	$61.00	+8.92%	4 qtrssince 2019-Q1	Decreased 0
DG DOLLAR GEN CORP	2.2M	$346.5M	2.2%	—	$108.54	+32.80%	4 qtrssince 2019-Q1	Decreased 0
MA MASTERCARD INCORPORATED	1.1M	$324.5M	2.1%	—	$254.00	+13.16%	4 qtrssince 2019-Q1	Decreased 0
AOS SMITH A O CORP	6.8M	$323.9M	2.1%	—	$42.29	+0.18%	4 qtrssince 2019-Q1	Increased 72
UNDelisted UNILEVER N V N Y SHS NEW	5.5M	$317.7M	2.0%	—	—	—	4 qtrssince 2019-Q1	Increased 57
Showing 20 of 1,108 results.1,088 more with Pro.PROUpgrade to see all →